We thank the National Center for Protein Sciences of Peking University for assistance with the radioactive experiments
The share approached 15% by week 88 in the longest trial, while clinical underweight remained below 0.5%. The signal clustered in lower-baseline deep responders
Injections are usually administered every 3-4 days or every 7 days
Solutions: Rotate injection sites more frequently Use new needle every time Clean site thoroughly with alcohol Let alcohol dry before injecting If persistent, reduce dose or switch to oral Usually harmless: Minor reactions common Should resolve within hours to days Not dangerous unless signs of infection (warmth, spreading redness, fever) No results after 4 weeks Problem: Not seeing expected healing or improvements
*These products are intended strictly for research, laboratory, and analytical purposes only
Women using oral contraceptives should use a non-oral method or add a backup method for 4 weeks after initiating tirzepatide and for 4 weeks after each dose increase due to potential reduced contraceptive effectiveness